Analyst Says Bristol-Myers Squibb (BMY) Among the Best 'Deep Value' Stocks to Buy
“Well, one of the kind of biggest deep value names today is going to be in healthcare, and that’s Bristol-Myers Squibb Co (NYSE:BMY). So, it’s a five-star rated stock.
Bristol Myers Squibb Co (BMY)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bayforest Capital Theodoros Tsagaris | 7,261 | $327,471 | -22% | 0.16% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $47.58 | 4,250 | $202,215.00 | 83,513 | 2025-04-25 | Filing | |
| $55.05 | 2,000 | $110,096.00 | 104,626 | 2025-02-20 | Filing | |
| $54.84 | 1,823 | $99,999.97 | 63,932 | 2025-02-14 | Filing | |
| $54.68 | 1,830 | $100,055.25 | 62,109 | 2024-11-01 | Filing | |
| $49.78 | 2,000 | $99,560.00 | 82,672 | 2023-12-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $47.33 | 56,000 | $2,650,480.00 | 167,379 | 2025-09-02 | Filing | |
| $44.23 | 378 | $16,718.94 | 5,066 | 2025-08-02 | Filing | |
| $38.01 | 97 | $3,701.83 | 0 | 2025-05-09 | Filing | |
| $55.62 | 700 | $38,930.50 | 11,760 | 2024-11-04 | Filing | |
| $61.25 | 17,986 | $1,101,642.50 | 27,868 | 2023-08-24 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,304,698 | $419,641,880 | 1.06% | |
| 2. | 6,810,632 | $307,159,503 | 0.44% | |
| 3. | 5,259,966 | $237,224,467 | 0.14% | |
| 4. | 3,217,719 | $145,119,127 | 0.49% | |
| 5. | 2,973,841 | $134,120,229 | 0.14% |
News See All
Top 10 Trending Stocks Everyone’s Watching in Q4
AI bubble warnings are growing on Wall Street as major technology companies continue to pour billions into AI projects and partnerships.
Citi Raises PT on Bristol-Myers Squibb Company (BMY) Stock
Bristol-Myers Squibb Company (NYSE:BMY) is one of the Best Beaten Down Stocks to Buy According to Hedge Funds.
12 Best Beaten Down Stocks to Buy According to Hedge Funds
According to BNY, a global financial services company, the US Fed is restarting rate cuts amid a softening of the labor market, while slowing job growth has prompted expectations of more cuts. Amidst...
insitro and Bristol Myers Squibb (BMY) Advance ALS Research with New AI-Powered Collaboration
On October 14, insitro, a leader in applying machine learning to drug discovery and development, and Bristol-Myers Squibb Company (NYSE:BMY) announced the ne...
11 Defensive Healthcare Dividend Stocks To Buy Now
US healthcare stocks have been under mounting pressure this year, largely due to policies introduced by the Trump administration.
Bristol-Myers Squibb (BMY) Expands Cell Therapy Portfolio with $1.5 Billion Orbital Therapeutics Deal
Bristol-Myers Squibb Company (NYSE:BMY) is a global pharmaceutical company.
11 Low PE High Dividend Stocks to Buy According to Analysts
A low price-to-earnings (P/E) ratio often indicates that a stock may be undervalued compared to its earnings, which makes it appealing to investors who ...
Bristol-Myers Squibb (BMY): Strong Growth Pipeline Supports High-Yield Dividend
Bristol-Myers Squibb Company (NYSE:BMY), headquartered in New Jersey, is a global pharmaceutical leader developing prescription drugs across areas such as oncology, hematology...
12 Best Dividend Stocks With Yields Above 4%
Investors often keep a close eye on the stock market, tracking price movements and hoping for gains.
Hedge Fund Resource Center Billionaire Hedge Funds
